On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

Test Results Boost Lexaria Bioscience Corp. (NASDAQ: LEXX) Potential in Enhancing Antiviral Drugs

Lexaria Bioscience has completed a study conducted by Canada’s National Research Council for the use of its DehydraTECH IP with five drugs known to target the main protease associated with SARS-CoV-2 infection, including remdesivir The SARS-CoV-2 infection is the underlying force behind the COVID-19 pandemic that has killed millions of people during the past year … Continue reading “Test Results Boost Lexaria Bioscience Corp. (NASDAQ: LEXX) Potential in Enhancing Antiviral Drugs”

420 with CNW — Five Science-Based Benefits of Cannabidiol

Cannabis and cannabis extracts are becoming more popular as more states across the country legalize the plant for recreational and/or medical use. CBD, or cannabidiol, is a chemical compound that is extracted from the cannabis sativa plant. The compound can be consumed through edible consumption or smoke inhalation, in addition to being applied topically. It … Continue reading “420 with CNW — Five Science-Based Benefits of Cannabidiol”

420 with CNW — Supreme Court Justice Slams Federal Cannabis Policy as Unstable, Contradictory

Until a decade or so ago, America’s policy on cannabis had been outright prohibition. Marijuana was illegal to grow, produce or sell in nearly every state, and individuals who participated in any of these activities were subject to intense policing and harsh sentencing. Now more than 30 states allow some form of cannabis, and the … Continue reading “420 with CNW — Supreme Court Justice Slams Federal Cannabis Policy as Unstable, Contradictory”

CannabisNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Eyes Potential Expansion of ‘Covid-ID Lab’

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, recently received the CE-IVD approval (European certification) of its 25-minute COVID-19 RT-PCR test kits (“Covid-ID Lab”). The approval facilitated initial sale and distribution of the Covid-ID Lab in Germany and, later, other parts of Europe, the Middle East and North America. The company … Continue reading “CannabisNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Eyes Potential Expansion of ‘Covid-ID Lab’”

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Targets Potential Expansion of Rapid COVID-19 Test Kit Distribution with Delivery of 2,000 Units to Israel

XPhyto recently delivered 2,000 of its rapid Covid-ID Lab test kits to an established Israeli distributor for clinical evaluation by the Ministry of Health The delivery, which marks entry into the Middle East, follows the approval of the test kits in Europe In an earlier interview, CEO Hugh Rogers had noted that XPhyto was looking … Continue reading “XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Targets Potential Expansion of Rapid COVID-19 Test Kit Distribution with Delivery of 2,000 Units to Israel”

420 with CNW — Senate Leaders Have First Meeting to Discuss Cannabis Legalization Plan

The past few years have seen several states legalize recreational or medical cannabis. By 2020, more than 30 states allowed cannabis in various forms, and there was hope that eventually the wave of cannabis reform would reach the federal level. Toward the end of the year, the U.S. House of Representatives passed a cannabis decriminalization … Continue reading “420 with CNW — Senate Leaders Have First Meeting to Discuss Cannabis Legalization Plan”

420 with CNW — Cannabis and Fibromyalgia: What Does Available Research Say?

Despite its controversial reputation, cannabis has been slowly but surely building a reputation as a potent and versatile alternative to pharmaceuticals. While most experts agree the hype around cannabis has far outpaced the science, preliminary studies and anecdotal evidence have found it to be effective against everything from stress and anxiety to chronic pain and … Continue reading “420 with CNW — Cannabis and Fibromyalgia: What Does Available Research Say?”

Savvy Companies Eye Promising Potential in Multi-Billion-Dollar Industry

CannabisNewsWire Editorial Coverage: A recent Data Bridge Market Research report notes that the once-hot cannabis industry looks to be heating up again — in a big way. The report includes predictions that the global legal marijuana market will total more than $90 billion by 2027. Smart companies are jostling for a strong position in this … Continue reading “Savvy Companies Eye Promising Potential in Multi-Billion-Dollar Industry”

420 with CNW – CBD Oil: A Natural Remedy for Anxiety and Depression

For most people, therapy and or medication helps to cope with anxiety and depression while some prefer meditation and yoga or both methods. Of late however, treatments for depression and anxiety have been moving towards more natural remedies, particularly CBD oil. Cannabidiol or CBD is a cannabinoid that exists in the cannabis sativa plant. The … Continue reading “420 with CNW – CBD Oil: A Natural Remedy for Anxiety and Depression”

420 with CNW – What Current Research Says About Marijuana and Memory

We all know the stereotype of the bumbling, forgetful stoner. Cannabis has for long been associated with memory loss, and that has been one of the main arguments against legalizing. However, most of these claims lacked any scientific backing but over the past few years, researchers have been steadily learning more about cannabis and its … Continue reading “420 with CNW – What Current Research Says About Marijuana and Memory”

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722